A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc.
Nimbus Therapeutics
Accent Therapeutics
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
Marengo Therapeutics, Inc.
OncoAtlas LLC
Fate Therapeutics
Fate Therapeutics
Apollomics (Australia) Pty. Ltd.
Incyte Corporation
Incyte Corporation